1
van Hunsel, Florence P A M, van der Kooi, Djurre, van de Koppel, Sonja, Kroes, Burt H, Woerdenbag, Herman J
Veröffentlicht in: van Hunsel , F P A M , van der Kooi , D , van de Koppel , S , Kroes , B H & Woerdenbag , H J 2022 , ' Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb ' , Drug Safety , vol. 45 , no. 6 , pp. 651-661 . https://doi.org/10.1007/s40264-022-01180-5;
2022
Veröffentlicht in: van Hunsel , F P A M , van der Kooi , D , van de Koppel , S , Kroes , B H & Woerdenbag , H J 2022 , ' Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb ' , Drug Safety , vol. 45 , no. 6 , pp. 651-661 . https://doi.org/10.1007/s40264-022-01180-5;
2022
2
Giraud, Eline L, Jessurun, Naomi T, van Hunsel, Florence P A M, van Puijenbroek, Eugene P, van Tubergen, Astrid, Ten Klooster, Peter M, Vonkeman, Harald E
Veröffentlicht in: Giraud , E L , Jessurun , N T , van Hunsel , F P A M , van Puijenbroek , E P , van Tubergen , A , Ten Klooster , P M & Vonkeman , H E 2020 , ' Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients ' , Expert Opinion on Drug Safety , vol. 19 , no. 12 , pp. 1617-1624 . https://doi.org/10.1080/14740338.2020.1830058 ; ISSN:1474-0338;
2020
Veröffentlicht in: Giraud , E L , Jessurun , N T , van Hunsel , F P A M , van Puijenbroek , E P , van Tubergen , A , Ten Klooster , P M & Vonkeman , H E 2020 , ' Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients ' , Expert Opinion on Drug Safety , vol. 19 , no. 12 , pp. 1617-1624 . https://doi.org/10.1080/14740338.2020.1830058 ; ISSN:1474-0338;
2020
3
4
5
6
7
8
9
Fens, T., van der Pol, S., Kocks, Janwillem W.H., Postma, Maarten J., van Boven, Job F.M.
Veröffentlicht in: Fens , T , van der Pol , S , Kocks , J W H , Postma , M J & van Boven , J F M 2019 , ' Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease : ISPOR’s guidance on budget impact in practice ' , Value in Health , vol. 22 , no. 10 , pp. 1092-1101 . https://doi.org/10.1016/j.jval.2019.05.006;
2019
Veröffentlicht in: Fens , T , van der Pol , S , Kocks , J W H , Postma , M J & van Boven , J F M 2019 , ' Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease : ISPOR’s guidance on budget impact in practice ' , Value in Health , vol. 22 , no. 10 , pp. 1092-1101 . https://doi.org/10.1016/j.jval.2019.05.006;
2019
10